Compile Data Set for Download or QSAR
Report error Found 36 Enz. Inhib. hit(s) with Target = 'Core-binding factor subunit beta'
TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123672(US8748618, AI-4-49)
Affinity DataIC50: 700nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123674(US8748618, AI-4-48)
Affinity DataIC50: 760nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123684(US8748618, LD-2-101)
Affinity DataIC50: 1.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123675(US8748618, AI-10-3)
Affinity DataIC50: 1.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123665(US8748618, AI-10-47)
Affinity DataIC50: 1.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123673(US8748618, LD-2-23)
Affinity DataIC50: 1.10E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123671(US8748618, AI-10-51)
Affinity DataIC50: 1.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123670(US8748618, LD-1-39)
Affinity DataIC50: 1.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123659(US8748618, AI-4-70 (or) LD-2-21)
Affinity DataIC50: 1.40E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123669(US8748618, AI-4-43)
Affinity DataIC50: 1.40E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123657(US8748618, LD-1-29 (or) AI-10-54)
Affinity DataIC50: 1.50E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123663(US8748618, AI-10-35)
Affinity DataIC50: 1.80E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123685(US8748618, AI-10-77)
Affinity DataIC50: 2.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123678(US8748618, AI-10-96)
Affinity DataIC50: 2.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM50180737(US8748618, LD-1-37 | CHEMBL371956 | 5,6-dimethyl-2...)
Affinity DataIC50: 2.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123654(US8748618, LD-1-127 | US8748618, AI-4-57 (or) LD-1...)
Affinity DataIC50: 2.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM50180732(CHEMBL166127 | US8748618, LD-2-79 | 5-Chloro-2-pyr...)
Affinity DataIC50: 2.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123681(US8748618, AI-10-87)
Affinity DataIC50: 2.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123680(US8748618, AI-10-11)
Affinity DataIC50: 2.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM50180735(CHEMBL199982 | US8748618, LD-1-31 | 5-fluoro-2-(py...)
Affinity DataIC50: 2.50E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123668(US8748618, LD-1-33)
Affinity DataIC50: 2.50E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123661(US8748618, AI-10-61)
Affinity DataIC50: 2.50E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123679(US8748618, AI-4-61 (or) AI-10-52)
Affinity DataIC50: 2.50E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123654(US8748618, LD-1-127 | US8748618, AI-4-57 (or) LD-1...)
Affinity DataIC50: 2.60E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM50180733(5-methyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole | 5...)
Affinity DataIC50: 2.90E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123682(US8748618, AI-10-53)
Affinity DataIC50: 3.00E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123664(US8748618, AI-10-37)
Affinity DataIC50: 3.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123676(US8748618, AI-10-88)
Affinity DataIC50: 3.40E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123658(US8748618, AI-4-42)
Affinity DataIC50: 4.20E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123667(US8748618, LD-1-23)
Affinity DataIC50: 4.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123662(US8748618, LD-1-138)
Affinity DataIC50: 4.60E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123666(US8748618, AI-4-46)
Affinity DataIC50: 5.30E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123656(US8748618, AI-4-52 | US10562890, Compound 4a)
Affinity DataIC50: 5.50E+3nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123654(US8748618, LD-1-127 | US8748618, AI-4-57 (or) LD-1...)
Affinity DataIC50: 1.60E+4nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123683(US8748618, AI-10-65)
Affinity DataIC50: 2.20E+4nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCore-binding factor subunit beta(Human)
University of Virginia Patent Foundation

US Patent
LigandPNGBDBM123677(US8748618, AI-10-57)
Affinity DataIC50: 4.00E+4nMAssay Description:We have developed effective assays to monitor the inhibition of CBFβ-SMMHC binding to the Runt domain (as well as for CBFβ binding to the R...More data for this Ligand-Target Pair
In DepthDetails
US Patent